| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 07/18/2003 | CA2369985A1 Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach |
| 07/17/2003 | WO2003057888A1 Cell-specific expression/replication vector |
| 07/17/2003 | WO2003057178A2 Viral capsid assembly intermediates |
| 07/17/2003 | WO2003038057A3 Genetic vaccine against human immunodeficiency virus |
| 07/17/2003 | WO2002074335A3 Equine herpesvirus vaccine |
| 07/17/2003 | US20030134817 SIV derived lentiviral vector systems |
| 07/17/2003 | US20030134404 Heating the mixture of empty and packaged capsids of adeno-associated virus (AAV) to a temperature of between 40-70 degree C. and adjusting the pH value of the mixture between 4-7 to remove empty AAV virus capsid from the mixture |
| 07/17/2003 | US20030134351 Intracellular proteins, messenger/signaling/hormone proteins and viral proteins |
| 07/17/2003 | US20030134350 Zinc finger domain recognition code and uses thereof |
| 07/17/2003 | US20030134297 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
| 07/17/2003 | US20030133948 An expression vector, comprising a) coding sequences for i) the viral nucleic acid-binding protein LANA ii) a therapeutic gene, and b) viral nucleic acid to which above viral nucleic acid-binding protein will bind |
| 07/17/2003 | US20030133929 Draining blood from the animal, separating blood cells from plasma, contacting plasma with a solvent in which lipids are soluble, separating plasma to reintroduce it into the animal, separating dissolved lipids |
| 07/17/2003 | US20030133911 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 07/17/2003 | US20030133829 Process for inactivating pathogens in a biological material |
| 07/17/2003 | CA2467083A1 Viral capsid assembly intermediates |
| 07/16/2003 | EP1326992A1 Method for circularizing adenoviral nucleic acid via homologous recombination |
| 07/16/2003 | EP1326990A2 Packaging of positive-strand rna virus replicon particles |
| 07/16/2003 | EP1326988A1 High efficiency retroviral vector which contains genetically engineered cellular non-coding sequence harboring splicing acceptor |
| 07/16/2003 | EP1326963A2 Nucleic acid amplification controls |
| 07/16/2003 | EP1019510B1 Vaccines derived from porcine circoviruses |
| 07/16/2003 | EP0789767B1 A method for producing purified papillomavirus proteins |
| 07/16/2003 | EP0760013B1 Treatment of influenza virus infection using antivirals that inhibit acylation/palmitylation of hemagglutinin |
| 07/16/2003 | CN1429910A Cotton bollworm single particle embedded nuclear polyhedrosis virus shuttle expression carrier and preparation method |
| 07/16/2003 | CN1429903A Fast donor plasmid carrying cotton bollworm single particle embedded nuclear polyhedrosis virus gene and P10 gene promotor sequence and construction method |
| 07/16/2003 | CN1429902A Recombination bollworm monokaryon capsid polyhedrosis virus for expression polghedrosis and chitinase fusion protein and its preparation method |
| 07/16/2003 | CN1114691C Phage having nuclear location signal |
| 07/16/2003 | CN1114690C Papilloma pseudovirus and process for preparing same |
| 07/15/2003 | US6593134 Propagation of chicken infectious anemia virus; prepare nutrient broth, inoculate with cells infected with marek's disease, propagate, recover infected cells |
| 07/15/2003 | US6593123 Large-scale recombinant adeno-associated virus (rAAV) production and purification |
| 07/15/2003 | US6593111 Generating genetically engineered viral genome; obtain clones, incubate with restriction enzymes, recover nucleotide sequence, ligate and generate viral genome |
| 07/15/2003 | US6593103 HIV capsid assembly-associated compositions and method |
| 07/15/2003 | US6593081 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 07/15/2003 | US6592874 Togavirus capsid particle that does not contain genomic or RNA vector replicon nucleic acids |
| 07/15/2003 | US6592873 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
| 07/10/2003 | WO2003056023A1 Double-stranded cyclic dna capable of proliferating as artificial e. coli chromosome |
| 07/10/2003 | WO2003055994A1 Hxhv virus, nucleic material, peptide material and uses |
| 07/10/2003 | WO2003055988A1 An avian embryo particulate biomass for the production of virus antigens |
| 07/10/2003 | WO2002089728A3 Recombinant rhabdoviruses as live-viral vaccines |
| 07/10/2003 | WO2002086154A3 Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages |
| 07/10/2003 | US20030130187 Porcine adenovirus type 3 genome |
| 07/10/2003 | US20030129744 Bvdv virus-like particles |
| 07/10/2003 | US20030129729 Genetic engineered Dna; attenuation, deactivation viruses |
| 07/10/2003 | US20030129728 Disrupting genes and mixing with plasmids/DNA vaccine; immunology; gene therapy; aging resistance |
| 07/10/2003 | US20030129727 Nucleic acid encoding 5'-3' exonuclease of bacteriophage RM 378 |
| 07/10/2003 | US20030129583 Testing for the ability of a stealth virus to induce the production of auto-fluorescent material in cells; destroying suspected stealth virus infected cells in a blood sample |
| 07/10/2003 | US20030129203 Rep proteins; fusion proteins; high throughput assay; gene therapy |
| 07/10/2003 | US20030129202 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
| 07/10/2003 | US20030129201 Methods of preventing and treating flavivirus infection in animals |
| 07/10/2003 | US20030129200 Inoculation using polymerases that have been deactivated using ultraviolet radiation or enzyme inhibitors such as azido dipyrodiazepinona and/or N-(4-chloro-3-(3-methyl-2-butenyloxy) phenyl)-2-methyl-3-furanocarbothiamide |
| 07/10/2003 | CA2471131A1 An avian embryo particulate biomass for the production of virus antigens |
| 07/09/2003 | EP1325960A2 Negative strand RNA virus vector having autonomously replicating activity |
| 07/09/2003 | EP1325931A1 Inhibitors of human neutrophil elastase |
| 07/09/2003 | CN1429270A Synthetic gagpol genes and their use |
| 07/09/2003 | CN1429235A Full-length infectious CDNA clones of tick borne flavivirus |
| 07/08/2003 | US6589782 VEGF (Vascular Endothelial Growth Factor); adenovirus vector; Use in treating cardiovascular disorders, enhancing the neovascularization of diseased blood vessels and enhancing drug delivery via improved vascular permeability |
| 07/08/2003 | US6589768 Deoxyribonucleotide deletion (3'end) in reverse transcriptase (RT) gene results in RT gene with DNA polymerase activity and no RNase H activity; fusion proteins; vectors; kits; use to synthesize cDNA from mRNA without RNase H degrading the mRNA |
| 07/08/2003 | US6589732 Transducing phages |
| 07/08/2003 | US6589533 Able to span or correctly integrate into cell membrane of insects but not mammals |
| 07/08/2003 | US6589531 Recombinant yellow fever virus and method of use thereof |
| 07/08/2003 | US6589522 Vaccines against infections caused by YF virus; YF infectious cDNA, method for producing a recombinant YF virus from the YF infectious cDNA and plasmids to assemble the YF infectious cDNA |
| 07/08/2003 | CA2301000C An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine |
| 07/03/2003 | WO2003054212A2 A method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral dna |
| 07/03/2003 | WO2003054210A2 Regulated nucleic acid expression system |
| 07/03/2003 | WO2003054199A2 Phytases and method for producing these phytases |
| 07/03/2003 | WO2003054175A1 Method for the recovery and purification of poxviruses from infected cells |
| 07/03/2003 | WO2003054174A1 Method for large scale production of virus antigen |
| 07/03/2003 | WO2003054173A1 Isolated phages and their use in food or pet food products |
| 07/03/2003 | WO2003054160A2 Cell lines with latent immunodeficiency virus and methods of use thereof |
| 07/03/2003 | WO2003053477A1 Process for inactivating pathogens in a biological solution |
| 07/03/2003 | WO2003053343A2 Novel compounds that enhance dimerization of the subunits of hiv-1 reverse transcriptase having mutations associated with resistance to nonnucleoside reverse transcriptase inhibitors |
| 07/03/2003 | WO2003026767A3 Lysin-deficient bacteriophages having reduced immunogenicity |
| 07/03/2003 | WO2002020049A3 Eiav chimeric vaccine and diagnostic |
| 07/03/2003 | US20030125541 Replication competent hepatitus C virus and methods of use |
| 07/03/2003 | US20030125262 Methods and reagents for regulation of cellular responses in biological systems |
| 07/03/2003 | US20030124708 Modification of virus tropism and host range by viral genome shuffling |
| 07/03/2003 | US20030124650 Isolating streptomyces serine proteases using immunoaffinity chromatography; oligopeptides |
| 07/03/2003 | US20030124517 Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof |
| 07/03/2003 | US20030124511 Method of production of purified hepatitis a virus particles and vaccine preparation |
| 07/03/2003 | US20030124146 Recombinant Rhabdoviruses as live-viral vaccines |
| 07/03/2003 | US20030124144 Chimeric capsid proteins and uses thereof |
| 07/03/2003 | US20030124096 DNA virus, which replicates via an RNA intermediate,that comprises a nucleotide mutation in a gene encoding a DNA polymerase or part thereof; particularly hepatitis B variants |
| 07/03/2003 | US20030121854 Complexing ligand with compound; separation, purification; chromatography |
| 07/03/2003 | CA2469644A1 Method for large scale production of virus antigen |
| 07/03/2003 | CA2467207A1 Novel phytases and method for producing these phytases |
| 07/03/2003 | CA2467099A1 Method for the recovery and purification of poxviruses from infected cells |
| 07/02/2003 | EP1323822A2 Transgenic Virus for use as pesticide |
| 07/02/2003 | EP1322755A1 Human and mouse targeting peptides identified by phage display |
| 07/02/2003 | EP1322329A1 Split enveloped virus preparation |
| 07/02/2003 | EP1322287A2 Microparticles for delivery of the heterologous nucleic acids |
| 07/02/2003 | EP1322169A1 Irreversible coating particles and compositions containing these particles |
| 07/02/2003 | EP0654089B1 Recombinant equine herpesviruses |
| 07/02/2003 | CN1427076A Combined deletion 19 Kda, 55KDA, E1B code sequence recombination adenovirus construction body and its use |
| 07/02/2003 | CN1427075A Recombination adenovirus construction body with deletion E1A code sequence and its use |
| 07/02/2003 | CN1113097C Processes for preparation of Marek's disease virus using continuous mammalian cell lines |
| 07/02/2003 | CN1113068C Materials for production of nanometer structure and use thereof |
| 07/02/2003 | CN1112934C Epidemic hemorrhagic fever passage cell polyvalent purified vaccine |
| 07/01/2003 | US6586226 Efficient purification of adenovirus |
| 07/01/2003 | US6586208 Controlling the generation of poisonous protein; obtain cell, transform with vector coding poisonous protein, express vector, recover protein |
| 07/01/2003 | US6586182 Selecting amino acid sequence variations based on computer modeling; polynucleotides comprising subsequences of nucleic acids encoding the amino acid variations; reassembling into nucleotide sequences encoding mutagenized polypeptides |
| 07/01/2003 | US6585978 EIA vaccine and diagnostic |